NRBO (NeuroBo) Yalpi marja

NeuroBo Pharmaceuticals Inc (NRBO) kompaniyasining rasmiy ramzlari

NeuroBo Pharmaceuticals (NRBO) kompaniyasining kredit profili metabolik sindromga qarshi og'iz orqali qabul qilinadigan dori vositalarini ishlab chiqishga asoslangan. Operatsion yalpi marja narxlar barqarorligini namoyish etadi, bunda 0.00 ushbu ko'rsatkichning joriy holatini tavsiflaydi. Moliyaviy rezervlar Janubiy Koreya korporatsiyalari bilan hamkorlik va MASH terapiyasi bo'yicha klinik sinovlar natijalariga bo'lgan kutishlar bilan mustahkamlanib, biznes qiymatining o'sishi uchun potentsial yaratmoqda.

NRBO (NeuroBo Pharmaceuticals, Inc.) Yalpi rentabellik tarixi 04.07.2022dan 07.12.2024gacha

neurobopharma.com (NRBO) moliyaviy va bozor koʻrsatkichlari kesimi

Fundamental baholash:NRBO NeuroBo
NeuroBo Pharmaceuticals ishlab chiqargan mahsulot

Yalpi foyda marjasi bevosita mahsulot yaratish xarajatlarini chegirib tashlagandan keyin qolgan daromad qismini aniqlash orqali ishlab chiqarish samaradorligini o'lchaydi. GURU.Markets platformasidagi yalpi foyda marjasi ulushining tendentsiyasi operatsion modelning sotilgan tovarlar tannarxi o'zgarishlariga sezgirligini aks ettiradi. Barqaror savdolarsiz klinik sinovlarga e'tibor qaratgan NeuroBo Pharmaceuticals (NRBO) uchun ushbu ko'rsatkich terapiyani tijoratlashtirishga o'tish davrida kelgusidagi daromadlilikning belgisi bo'lib xizmat qiladi.

Muhim raqobatchilar

Yalpi foyda bo'yicha rentabellik Biogen Corp|Yalpi foyda bo'yicha rentabellik NBIX|Regencell Corp (RGC) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja AXSM|Yalpi foyda bo'yicha rentabellik ACADIA Pharmaceuticals ACAD|Yalpi marja XENE (Xenon Pharmaceuticals Inc.)|VKTX (Viking Therapeutics, Inc.) - Yalpi foyda bo'yicha marjinallik|SUPN - Yalpi rentabellik|Catalyst Pharmaceuticals Inc (CPRX) - Yalpi foyda bo'yicha rentabellik|DNLI (Denali Corp) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi harmonybiosciences.com (HRMY)|Yalpi foyda bo'yicha rentabellik BHVN|Yalpi marja Amylyx|Yalpi marja TRVI|PRAX (Praxis Corp) - Yalpi foyda normasi|Yalpi marja AVXL (anavex.com)|CBLL: Sotuvning yalpi rentabelligi|PRTA - Yalpi rentabellik|ALEC - Yalpi marja|Annexon Inc. (ANNX) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Omeros Corp|Yalpi foyda bo'yicha rentabellik NGNE|ACIU: Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik VYGR (Voyager Corp)|Yalpi foyda bo'yicha rentabellik Neumora NMRA|Yalpi rentabellik Scilex Holding Company, Inc. SCLX|Sotuvning yalpi marjinal rentabelligi Tevogen Bio Inc.|ACOG - Yalpi rentabellik|Sotuvning yalpi marjinal rentabelligi Cognition Therapeutics (CGTX)|IKT (Inhibikase Therapeutics) - Yalpi foyda bo'yicha rentabellik|Cassava Sciences Inc (SAVA) - Yalpi marja|Yalpi foyda bo'yicha rentabellik ASRT|Yalpi marja coyatherapeutics.com|Yalpi marja VTGN|Ovid Therapeutics - Sotuvning yalpi rentabelligi|Yalpi marja ABOS (Acumen Pharmaceuticals, Inc)|CRVO - Yalpi foyda bo'yicha rentabellik|ATHE - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi clene.com CLNN|PEPG: Yalpi marja|Sotuvning yalpi rentabelligi JUNS|RLMD (Relmada Corp) - Yalpi marja|Annovis Bio Inc (ANVS) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Grace Therapeutics, Inc. (GRCE)|AIFF (Firefly Neuro) - Yalpi foyda normasi|Yalpi rentabellik Klotho Neurosciences KLTO|NRSN: Sotuvning yalpi rentabelligi|RVPH: Yalpi foyda bo'yicha rentabellik|MTVA: Yalpi rentabellik|NRXS (NeurAxis Inc) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha rentabellik Helius Medical Technologies, Inc.|Yalpi rentabellik Passage Bio Inc.|Yalpi foyda marjasi bionomics.com.au NEUP|Yalpi marja NERV|Yalpi marja Athira Pharma Inc (ATHA)|Yalpi marja ADXN (Addex Therapeutics Ltd.)|ALZN: Sotuvning yalpi rentabelligi|CYCN - Yalpi rentabellik|Yalpi foyda marjasi Protagenic Therapeutics, Inc.|KTTA (pasitheaclinics.com) - Yalpi foyda bo'yicha rentabellik|Sotuvning yalpi marjinal rentabelligi Cortigent, Inc. CRGT|Yalpi rentabellik Avenue Therapeutics, Inc.|Yalpi foyda bo'yicha rentabellik BrainStorm Cell Therapeutics Inc. (BCLI)|Yalpi rentabellik Cara Therapeutics, Inc (CARA)|Yalpi rentabellik CHRO (Chromocell Therapeutics Corp.)|Yalpi marja ELYM (eliemtx.com)|intracellulartherapies.com - Yalpi rentabellik|LBPH: Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi MRNS (Marinus Pharma)|NKGN (nkgenbiotech.com) - Yalpi foyda bo'yicha rentabellik|SAGE: Yalpi foyda koeffitsiyenti|Yalpi rentabellik Synaptogenix, Inc.|Yalpi rentabellik TRVN|Yalpi marja VIGL|Yalpi marja anewmeds.com (WENA)|Yalpi marja CERE (cerevel.com)